he expression of herpes simplex virus type 1 (HSV-1) genes is sequentially ordered in a cascade fashion. The ␣ (immediateearly) genes are expressed first, followed by the ␤ (early) and ␥ (late) genes (1, 2) . Optimal expression of the ␣ genes requires the interaction of a complex of proteins containing host factor 1 (HCF1), octamer binding protein 1 (Oct1), and virion protein 16 (VP16) that is packaged in the virion with the response element GnTAATGArTTC in the promoters of the ␣ genes (reviewed in reference 3). This complex recruits transcriptional factors. Recently, it has been reported that the HCF1/Oct1/VP16 complex recruits lysine-specific demethylase 1 (LSD1) to demethylate histones bound to the ␣ promoters (4). LSD1 demethylates both H3K4 and H3K9 and thereby acts as a coactivator or as a corepressor, depending on the context (5, 6) .
The transition from ␣ to ␤ and ␥ gene expression requires the expression of several ␣ proteins and, most notably, infected cell protein 0 (ICP0), ICP4, ICP22, and ICP27 (reviewed in reference 2). Recent studies from this and other laboratories have focused on the role of ICP0 in the transition from ␣ to ␤ gene expression. Briefly, at low multiplicities of infection in the absence of ICP0, ␣ genes are expressed, but the transition from ␣ to ␤ gene expression does not ensue (7) (8) (9) (10) . ICP0 is a large 775-residue multifunctional protein. Immediately after synthesis, ICP0 localizes at ND10 nuclear bodies, and its primary functions are to suppress innate immunity in part by degradation of promyelocytic leukemia (PML) and dispersal of the ND10 bodies and to act as a promiscuous transactivator of genes introduced into cells by infection or transfection (reviewed in reference 3). Specifically, ICP0 contains a domain homologous to a sequence contained at the N terminus of CoREST, a component of the HDAC1 or 2/LSD1/CoREST/REST (HLCR) repressor complex (11, 12) . In vitro, ICP0 interacts with the N terminus of CoREST and displaces HDAC1 from the repressor complex (11, 12) . In infected cells, components of the HLCR complex are partially dispersed and displaced from the nucleus to the cytoplasm (11) . Direct evidence that ICP0 enables the transition from ␣ to ␤ gene expression emerged from studies showing that dominant negative CoREST incapable of binding HDAC1 complemented ⌬ICP0 mutants at low multiplicities of infection in a cell type-dependent manner (12) . These studies led to the conclusion that the cell recruits the HLCR repressor complex to ND10 structures in an attempt to suppress the expression of genes introduced by infection or transfection and that ICP0 suppresses the attempt by the cell to silence viral DNA.
The studies reported here followed up the observation that the HCF1/Oct1/VP16 complex recruits LSD1 to demethylate histones bound to the ␣ promoters (4). LSD1 is unstable by itself and generally requires CoREST for its activity (5, 13) . CoREST in turn may partner with REST (14-16). The question therefore arose whether to initiate transcription HCF1/Oct1/VP16 recruits, along with LSD1, both CoREST and REST. In this report, we show that suppression of the accumulation of REST or CoREST with the appropriate small interfering RNA (siRNA) leads to decreased levels of REST, CoREST, LSD1, and Sin3a, components of the HLCR repressor complex. In cells transfected with the CoREST siRNA (siCoREST) or REST siRNA (siREST), there was a delay in the accumulation of viral ␣ gene transcripts and proteins. Thus, the HLCR complex plays a dual role in the expression of viral genes. It is necessary for the activation of transcription of the ␣ genes, but it is inimical and must be disrupted for the transition of ␣ to ␤ and ␥ gene expression. Lysates containing 70 g of total proteins were separated on denaturing 8% polyacrylamide gels, electrically transferred to nitrocellulose sheets, and immunoblotted for REST, CoREST, LSD1, Sin3A, and ␤-actin proteins, as described in Materials and Methods. The images were scanned with the aid of ImageJ, and the density of the bands was normalized with respect to the density of the proteins in mock-treated infected cells. fected or transfected with 100 pmol of REST siRNA, CoREST siRNA, or a control siRNA. At 48 h after transfection, the cells were exposed to 0.01 (Fig. 3A) or 1 ( Fig. 3B ) PFU of HSV-1(F) per cell. The cells were harvested at 1, 2, 4, or 6 h (1 PFU/cell) or 1, 2, 4, 6, or 10 h (0.01 PFU/cell) after a 30-min interval of adsorption. Total RNA was extracted, reverse transcribed, and used as a template for the quantification of the ICP27 or ICP22 transcripts accumulating in the cells. Figure 3A and B, top, shows the threshold cycle (C T ) values of the viral mRNAs subtracted from the respective C T values of the 18S rRNA. ⌬C T values were plotted as a function of the time of harvest of the cells. Figure 3A At 48 h after transfection, the cells were rinsed and exposed to 1 PFU of HSV-1(F) per cell. The cells were harvested at 4 and 6 h after infection. The cells were lysed, and 70 g of total proteins was electrophoretically separated on a denaturing 8% polyacrylamide gel, transferred to a nitrocellulose sheet, and reacted with the ␤-actin, ICP4, ICP0, ICP27, ICP22, or ICP8 antibodies. The density of the bands was normalized with respect to the density of proteins in mock-treated infected cells. We conclude that efficient accumulation of ␣ gene transcripts requires the presence of at least some components of the HLCR complex in addition to LSD1. The results also suggest that the extent of delay in the accumulation of viral mRNA transcripts is independent of the multiplicity of infection. Thus, the transcription of the ␣ genes in siRNA-treated cells is most likely due to the incomplete suppression of the components of the HLCR complex. We cannot exclude the possibility that other demethylases can substitute for LSD1 under certain conditions.
RESULTS

Knockdown of
The accumulation of wild-type virus is delayed in cells transfected with anti-REST or anti-CoREST siRNA. In these experiments, replicate cultures of U251 cells were mock treated or transfected with REST or CoREST siRNA. At 48 h after transfection, the cells were exposed to 0.1 PFU of the HSV-1(F) virus strain per cell. The inoculum was removed at 1 h after infection, and the cells were rinsed and harvested at 1, 2, 4, 8, 24, and 48 h after infection. The results shown in Fig. 4 indicate that the accumulation of virus in cells transfected with siRNA is reduced by as much as 10-fold at least through the first 24 h after infection.
DISCUSSION
As noted in the introduction, HSV-1 genes form at least three operationally defined groups whose expression is sequentially ordered (1, 2). The studies presented in this report and in the supporting literature indicate that the cell attempts to silence the viral DNA upon release of the DNA into the nucleus and that the virus overcomes the silencing in at least two distinct steps. The first step involves transactivation of the ␣ genes. In this instance, a complex consisting of VP16, Oct1, and HCF-1 binds to the GnTAATGArTTC response elements in the promoters of the ␣ genes and recruits transcriptional factors (reviewed in reference 3). A key recent discovery that the complex recruits LSD1 to demethylate the histones bound to the ␣ promoters led to the current studies (3). In brief, LSD1 is unstable in the absence of CoREST, to which it is bound. The studies presented here show that this is in fact the case. Thus, treatment of cells with either siRNA against REST or siRNA against CoREST resulted in destabilization of LSD1, REST, CoREST, and Sin3A, another component of the HLCR complex. Even though the suppression of the accumulation of REST or CoREST was not complete, in each case there was a delay in the expression of ␣ proteins and mRNA and a decrease in virus yield. A fundamental conclusion of these studies is that by recruiting LSD1, HSV also recruits to the ␣ promoters CoREST and REST, the key components of the HLCR complex.
The evidence in support of a second step in the suppression of silencing emerged from the observation that in cells infected with ⌬ICP0 mutant virus at low ratios of virus particles per cell, the transition from ␣ to ␤ gene expression does not ensue, and the virus is effectively silenced (7) (8) (9) (10) . The block to the transition from ␣ to ␤ gene expression in cells infected with the ⌬ICP0 mutant can be overcome in part by HDAC inhibitors (9, 10) or more effectively by overexpression of dominant negative CoREST expressed by a gene inserted into the ⌬ICP0 viral genome. Dominant negative CoREST retains its binding site for REST but is incapable of binding HDAC1 (12) . Additional players in blocking silencing are the viral protein kinases that mediate the phosphorylation of HDAC1 and 2 and CoREST (9, 10) . The conclusions to be drawn from these studies are that the CoREST/REST complex as a chaperone of LSD1 plays an important role in the activation of ␣ gene promoters but is inimical to the activation of ␤ and ␥ genes.
A key question that remains unsolved is how components of the same HLCR complex activate gene expression at one site but repress gene expression at other sites. One possible explanation rests in part on the evidence that the function of LSD1 as a coactivator or corepressor is dependent on the context in which it is present. We may speculate that at ␣ promoters, VP16/Oct1/HCF1 recruit to their response elements LSD1 and attendant CoREST/ REST proteins. In contrast, in the repression of ␤ and ␥ genes, as illustrated in Fig. 5 , it is REST bound to its response element that recruits CoREST and LSD1. The difference in the manner in which the repressor complex is anchored to the DNA may define the function of LSD1.
The results presented in this and earlier reports suggest that the HSV-1 genome is intimately involved with the HLCR complex at multiple steps in its interaction with the host cells. In productively infected cells, the HLCR complex is involved in the activation of the ␣ gene and in the abortive attempt to silence ␤ and ␥ genes expression. The abortive attempt to silence ␤ and ␥ gene expression makes sense when viewed from the perspective of latent in- fections. Thus, in sensory neurons committed to the establishment of the latent state, VP16 is not transported to the nucleus (17) . In the absence of ␣ proteins and, in particular, of ICP0, the silencing of the viral genome by the HLCR complex is not suppressed. The evidence supporting this model is based on studies showing that insertion into the wild-type genome of the mutated REST gene devoid of repressor binding sites and driven by the simian virus 40 (SV40) promoter results in a virus with diminished capacity to establish latency and increased virulence (18) , that is, a virus that cannot be silenced by the HLCR complex.
In essence, HSV-1 has evolved a special relationship with the ubiquitous HLCR repressor complex and uses it for all aspects of its lifestyle.
MATERIALS AND METHODS
Cells and virus strains. Vero cells were obtained from the American Type Culture Collection. The U251-MG (U251) human glioma cell line was a gift from the laboratory of G. Y. Gillespie (University of Alabama at Birmingham). The U251 cells were maintained in 5% fetal bovine serum in an atmosphere of 8% CO 2 . HSV-1(F) is the prototype HSV-1 strain used in this laboratory (19) .
Knockdown of REST/CoREST protein levels in U251 cells by RNA interference (RNAi). All transfections were carried out using Lipofectamine 2000 (Invitrogen) by following the manufacturer's instructions. The target sequence of the REST siRNA was 5= GUGAUACUGUA GAUUACAC 3=, and that of the coREST siRNA was 5= AAGAUUGUCC CGUUCUUGACU 3=. The sequence of irrelevant siRNA was 5= UUGAU GUGUUUAGUCGCUA 3=. All siRNAs were purchased from Invitrogen. U251 cells were transfected with siRNA to a final concentration of 200 pmol/2 ϫ 10 6 cells and incubated for 48 h after transfection.
Antibodies. Rabbit polyclonal anti-REST antibody was purchased from Novus Biologicals (Littleton, CO). Polyclonal anti-CoREST antibody was a kind gift from Gail Mandel (University of Oregon). Rabbit polyclonal anti-LSD1 was purchased from Abcam (Cambridge, MA). Monoclonal anti-Sin3A was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Mouse monoclonal anti-ICP4, anti-ICP8, and anti-ICP27 were purchased from Rumbaugh-Goodwin Institute for Cancer Research, Inc. (Plantation, FL). Anti-ICP0 exon 2 rabbit polyclonal antibody (20) and rabbit polyclonal antibody specific for the carboxyl terminus of ICP22 (21) were described elsewhere. The mouse monoclonal antibody to ␤-actin was purchased from Sigma (St. Louis, MO).
Immunoblots. The cells were harvested at the indicated times after infection by scraping into their medium, rinsed with phosphate-buffered saline (PBS), solubilized in triple detergent buffer (50 mM Tris-HCl [pH 8], 150 mM NaCl, 0.1% sodium dodecyl sulfate, 1% Nonidet P-40, 0.5% sodium deoxycholate, 100 g ml Ϫ1 of phenylmethylsulfonyl fluoride), supplemented with phosphatase inhibitors (10 mM NaF, 10 mM ␤-glycerophosphate, 0.1 mM sodium vanadate) and protease inhibitor cocktail (Sigma) as specified by the manufacturer, and briefly sonicated. The protein concentration of the supernatant fluids was determined with the aid of the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA), according to directions provided by the manufacturer. Samples containing 70 g of protein each were denatured in disruption buffer (50 mM Tris [pH 7.0], 2.75% sucrose, 5% ␤-mercaptoethanol, 2% sodium dodecyl sulfate), boiled for 5 min, electrophoretically separated in an 8% denaturing polyacrylamide gel, electrically transferred to a nitrocellulose sheet, blocked, and then reacted overnight at 4°C with the appropriate primary antibodies diluted in PBST-1% nonfat milk. The protein bands were scanned with ImageJ.
Total RNA isolation and real-time PCR analyses. Total RNAs were extracted with the aid of Tirol reagent (Invitrogen), according to the manufacturer's instructions, and then standardized by optical density measurements. DNA treatment (Ambion) was then done to degrade contaminating DNA. First-strand pcDNA synthesis using 1 g of total RNA and olio (dT) was done with the Superscription Rest-Strand Synthesis system for reverse transcriptase (RT)-PCR (Invitrogen), according to instructions provided by the suppliers. pcDNA synthesis mixtures were used for quantification of ICP22 and ICP27 transcripts by using a Sybr GreenER qPCR supermix universal kit (Invitrogen), according to the manufacturer's instructions. Samples without RT served as controls. The primers for ICP27 were 5= CGGGCCTGATCGAAATCCTA 3= (forward) and 5= GAC ACGACTCGAACACTCCT 3= (reverse), and those for ICP22 were 5= CG GAGTGTGATCTTAGTAATCTCG 3= (forward) and 5= AGATCGGTGG CATCGGAGATTT 3= (reverse). All the transcripts were normalized with respect to the levels of 18S rRNAs. The 18S rRNAs were assayed with the aid of the 18S rRNA universal primers (Ambion). The assays were performed on a StepOnePlus system (Applied Biosystems) and analyzed with software provided by the supplier.
Virus titration. U251 cells were exposed to 0.1 PFU of HSV-1(F) at 48 h after mock treatment or transfection with siREST or siCoREST. After 30 min of exposure, the cells were rinsed and reincubated in fresh medium. The cells were harvested at 1, 2, 4, 8, 24, and 48 h after the initial adsorption interval and gently sonicated to release the virus. Viral progeny was titrated on Vero cells. 
